Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer

Por Lo, Pang-Kuo, Lee, Ji Shin, Liang, Xiaohui, Han, Liangfeng, Mori, Tsuyoshi, Fackler, Mary Jo, Sadik, Helen, Argani, Pedram, Pandita, Tej K., Sukumar, Saraswati
Publicado em 2010

HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression

Por Shah, Nilay, Jin, Kideok, Cruz, Leigh-Ann, Park, Sunju, Sadik, Helen, Cho, Soonweng, Goswami, Chirayu Pankaj, Nakshatri, Harikrishna, Gupta, Rajnish, Chang, Howard Y., Zhang, Zhe, Cimino-Mathews, Ashley, Cope, Leslie, Umbricht, Christopher, Sukumar, Saraswati
Publicado em 2013

Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate

Por Korangath, Preethi, Teo, Wei Wen, Sadik, Helen, Han, Liangfeng, Mori, Noriko, Huijts, Charlotte M., Wildes, Flonne, Bharti, Santosh, Zhang, Zhe, Santa-Maria, Cesar A., Tsai, Hualing, Dang, Chi V., Stearns, Vered, Bhujwalla, Zaver M., Sukumar, Saraswati
Publicado no Clin Cancer Res (2015)

HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells

Por Sadik, Helen, Korangath, Preethi, Nguyen, Nguyen, Gyorffy, Balazs, Kumar, Rakesh, Hedayati, Mohammad, Teo, Wei Wen, Park, Sunju, Panday, Hardik, Munoz, Teresa Gonzalez, Menyhart, Otilia, Shah, Nilay, Pandita, Raj K., Chang, Jenny C., DeWeese, Theodore, Chang, Howard Y., Pandita, Tej K., Sukumar, Saraswati
Publicado no Cancer Res (2016)

Combined treatment with epigenetic, differentiating, and chemotherapeutic agents cooperatively targets tumor-initiating cells in triple negative breast cancer

Por Merino, Vanessa F., Nguyen, Nguyen, Jin, Kideok, Sadik, Helen, Cho, Soonweng, Korangath, Preethi, Han, Liangfeng, Foster, Yolanda M. N., Zhou, Xian C., Zhang, Zhe, Connolly, Roisin M., Stearns, Vered, Ali, Syed Z., Adams, Christina, Chen, Qian, Pan, Duojia, Huso, David L., Ordentlich, Peter, Brodie, Angela, Sukumar, Saraswati
Publicado no Cancer Res (2016)